Validation of Artificial Intelligence as Decision Support System in VIA (PRESCRIP-TEC)

NAActive, not recruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
HPV InfectionCervix CancerCervical Dysplasia
Interventions
DIAGNOSTIC_TEST

Validation of AI-DSS in Bangladesh

VIA procedure, taking pre-colouring and post-colouring pictures. First VIA assessment by health worker, followed by AI-DSS assessment. Independent panel of gynaecologists also assessed pictures. The panel assessment serves as reference value to calculate accuracy, sensitivity and specificity of health worker and AI-DSS.

DIAGNOSTIC_TEST

Validation of AI-DSS in Uganda

VIA procedure, taking pre-colouring and post-colouring pictures. First VIA assessment by health worker, followed by AI-DSS assessment. Independent panel of gynaecologists also assessed pictures. The panel assessment serves as reference value to calculate accuracy, sensitivity and specificity of health worker and AI-DSS.

DIAGNOSTIC_TEST

Validation of AI-DSS in India

VIA procedure, taking pre-colouring and post-colouring pictures. First VIA assessment by health worker, followed by AI-DSS assessment. Independent panel of gynaecologists also assessed pictures. The panel assessment serves as reference value to calculate accuracy, sensitivity and specificity of health worker and AI-DSS.

Trial Locations (1)

Unknown

Mpasana, Kakumiro

All Listed Sponsors
collaborator

Uganda Cancer Institute

OTHER

collaborator

Female Cancer Foundation

UNKNOWN

collaborator

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

collaborator

Manipal Academy for Higher Education

UNKNOWN

collaborator

Friendship Bangladesh

UNKNOWN

lead

University Medical Center Groningen

OTHER

NCT06452004 - Validation of Artificial Intelligence as Decision Support System in VIA (PRESCRIP-TEC) | Biotech Hunter | Biotech Hunter